Sort   by:  
 Page size 
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownCircuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
Not available
S-EPMC7987233 | biostudies-literature
UnknownComparing Nasopharyngeal and BAL SARS-CoV-2 Assays in Respiratory Failure.
Not available
S-EPMC7781122 | biostudies-literature
UnknownIndividual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.
Not available
S-EPMC10205601 | biostudies-literature
UnknownDistinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.
Not available
S-EPMC11490290 | biostudies-literature
UnknownLarge language models accurately identify immunosuppression in intensive care unit patients.
Not available
S-EPMC12490808 | biostudies-literature
Sort   by:  
 Page size